Clinical trial Recruiting at 1 site Observational Ages 18 and up

Laser speckle imaging to monitor leg perfusion before, during and after revascularization

Official title: SPECTATOR: Perfusion Monitoring Before, During and After Lower Extremity Revascularization With Laser Speckle Contrast Imaging

Run by Leiden University Medical Center · NCT07558174 · Data updated 2026-11-12

This study tries a non-invasive laser speckle imaging method to see if it can measure blood flow in the legs of people having lower-extremity revascularization.

More Peripheral Vascular Diseases trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorLeiden University Medical Center
Academic / other
Locations1 site (Leiden, South Holland)
StatusRecruiting
StartedSeptember 2026
Main results expectedMay 2028
Study endsJune 2028
Registry record updatedSeptember 23, 2026
Trial IDNCT07558174 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults scheduled for lower-extremity revascularization at Leiden University Medical Center who will have pre- and postoperative ICG NIRF measurements and can give informed consent.

Probably not a fit

Patients who are not undergoing revascularization, cannot undergo ICG NIRF imaging as required by the protocol, or have medical conditions judged by investigators to jeopardize safety are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will use laser speckle contrast imaging (LSCI) to record real-time perfusion of the lower limb before, during, and after revascularization procedures. LSCI measurements will be performed perioperatively and compared with standard indocyanine green near-infrared fluorescence (ICG NIRF) and temperature readings to explore correlations. Participants are patients scheduled for lower-extremity revascularization at Leiden University Medical Center who undergo pre- and postoperative ICG NIRF imaging. The study aims to test feasibility and signal quality of LSCI as a quick, dye-free alternative for bedside perfusion monitoring.

Why it matters

Potential benefit: If successful, LSCI could offer a quick, non-invasive way to visualize limb perfusion during revascularization and help surgeons predict or improve outcomes without dye injection.

How similar studies have gone: ICG NIRF has shown promise for guiding revascularization, but LSCI is a newer, non-invasive modality with limited prior clinical validation in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Scheduled for lower-extremity revascularization
* Undergoing pre- and postoperative indocyanine near-infrared fluorescence perfusion measurements

Exclusion Criteria:

Any condition that the investigator considers to be potentially jeopardizing the patient's wellbeing or the study objectives

Where it's running

  • Leiden University Medical Center
    Leiden, South Holland, Netherlands
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.